Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Published:2024-09 Issue:5 Volume:31 Page:e628-e633
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Jaber Fouad¹^ORCID,Salahat Ahmed-Jordan²,Alsakarneh Saqr¹,Alsharaeh Tala²,Jaber Mohammad³,Gangwani Manesh Kumar⁴,Mohamed Islam¹,Aldiabat Mohammad⁵⁶,Kilani Yassine⁷,ALi Hassam⁸,Ghoz Hassan⁹

Affiliation:

1. Department of Internal Medicine, University of Missouri Kansas City, Kansas City, MO

2. Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan

3. Faculty of Medicine, Al-Azhar University, Gaza, Palestine

4. Department of Internal Medicine, University of Toledo, Toledo, OH

5. Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO

6. Department of Epidemiology, Harvard School of Public Health, Boston, MA

7. Department of Internal Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College, Bronx, NY

8. Department of Gastroenterology, ECU Health Medical Center, Greenville, NC

9. Division of Gastroenterology and Hepatology, University of Missouri Kansas City, Kansas City, MO

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference18 articles.

1. Endoscopic retrograde cholangiopancreatography-related adverse events: general overview;Rustagi;Gastrointest Endosc Clin N Am.,2015

2. An insight on pharmacological and mechanical preventive measures of post-ercp pancreatitis (PEP)—a review;Zhang;Gastroenterology Insights,2022

3. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review;Kubiliun;Clin Gastroenterol Hepatol.,2015

4. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial;Luo;Lancet,2016

5. Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients;Del Olmo Martínez;Rev Esp Enferm Dig.,2018